Cerulean Announces Publication Showing CRLX101 Targets Breast Cancer Stem Cells and Impedes Resistance to Anti …

Cerulean Pharma Inc. , a leader in Dynamic Tumor Targeting™, today announced the publication of a manuscript in Breast Cancer Research and Treatment, describing precli